Header Logo

Connection

Caroline Tiemessen to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Caroline Tiemessen has written about Clinical Trials, Phase III as Topic.
Caroline Tiemessen
Connection Strength
0,154
Clinical Trials, Phase III as Topic
  1. The FCGR2C allele that modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in HIV-1 disease progression. Genes Immun. 2019 11; 20(8):651-659.
    View in: PubMed
    Score: 0,154
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.